Effects of Alzheimer's and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer's Disease
- PMID: 33664644
- PMCID: PMC7921324
- DOI: 10.3389/fnins.2021.606600
Effects of Alzheimer's and Vascular Pathologies on Structural Connectivity in Early- and Late-Onset Alzheimer's Disease
Abstract
Early- and late-onset Alzheimer's disease (AD) patients often exhibit distinct features. We sought to compare overall white matter connectivity and evaluate the pathological factors (amyloid, tau, and vascular pathologies) that affect the disruption of connectivity in these two groups. A total of 50 early- and 38 late-onset AD patients, as well as age-matched cognitively normal participants, were enrolled and underwent diffusion-weighted magnetic resonance imaging to construct fractional anisotropy-weighted white matter connectivity maps. [18F]-THK5351 PET, [18F]-Flutemetamol PET, and magnetic resonance imaging were used for the evaluation of tau and related astrogliosis, amyloid, and small vessel disease markers (lacunes and white matter hyperintensities). Cluster-based statistics was performed for connectivity comparisons and correlation analysis between connectivity disruption and the pathological markers. Both patient groups exhibited significantly disrupted connectivity compared to their control counterparts with distinct patterns. Only THK retention was related to connectivity disruption in early-onset AD patients, and this disruption showed correlations with most cognitive scores, while late-onset AD patients had disrupted connectivity correlated with amyloid deposition, white matter hyperintensities, and lacunes in which only a few cognitive scores showed associations. These findings suggest that the pathogenesis of connectivity disruption and its effects on cognition are distinct between EOAD and LOAD.
Keywords: amyloid; early-onset AD; late-onset AD; positron emission tomography; small vessel disease; tau; white matter connectivity.
Copyright © 2021 Lee, Yoon, Kim, Jeong, Seo, Na, Noh and Seong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Association of Subcortical Structural Shapes With Tau, Amyloid, and Cortical Atrophy in Early-Onset and Late-Onset Alzheimer's Disease.Front Aging Neurosci. 2020 Oct 26;12:563559. doi: 10.3389/fnagi.2020.563559. eCollection 2020. Front Aging Neurosci. 2020. PMID: 33192457 Free PMC article.
-
Effects of the APOEɛ4 Allele on the Relationship Between Tau and Amyloid-β in Early- and Late-Onset Alzheimer's Disease.J Alzheimers Dis. 2023;94(3):1233-1246. doi: 10.3233/JAD-230339. J Alzheimers Dis. 2023. PMID: 37393505
-
Alterations of Structural Network Efficiency in Early-Onset and Late-Onset Alzheimer's Disease.J Clin Neurol. 2024 Feb 5. doi: 10.3988/jcn.2023.0092. Online ahead of print. J Clin Neurol. 2024. PMID: 38330417
-
Spreading of amyloid, tau, and microvascular pathology in Alzheimer's disease: findings from neuropathological and neuroimaging studies.J Alzheimers Dis. 2014;42 Suppl 4:S421-9. doi: 10.3233/JAD-141461. J Alzheimers Dis. 2014. PMID: 25227313 Review.
-
Recent publications from the Alzheimer's Disease Neuroimaging Initiative: Reviewing progress toward improved AD clinical trials.Alzheimers Dement. 2017 Apr;13(4):e1-e85. doi: 10.1016/j.jalz.2016.11.007. Epub 2017 Mar 22. Alzheimers Dement. 2017. PMID: 28342697 Free PMC article. Review.
Cited by
-
Marine Sources of DHA-Rich Phospholipids with Anti-Alzheimer Effect.Mar Drugs. 2022 Oct 25;20(11):662. doi: 10.3390/md20110662. Mar Drugs. 2022. PMID: 36354985 Free PMC article. Review.
-
Unified framework for brain connectivity-based biomarkers in neurodegenerative disorders.Front Neurosci. 2022 Sep 20;16:975299. doi: 10.3389/fnins.2022.975299. eCollection 2022. Front Neurosci. 2022. PMID: 36203805 Free PMC article.
-
Progressive Vascular Abnormalities in the Aging 3xTg-AD Mouse Model of Alzheimer's Disease.Biomedicines. 2022 Aug 13;10(8):1967. doi: 10.3390/biomedicines10081967. Biomedicines. 2022. PMID: 36009514 Free PMC article.
-
Gender Differences in Demographic and Pharmacological Factors in Patients Diagnosed with Late-Onset of Alzheimer's Disease.Brain Sci. 2022 Jan 26;12(2):160. doi: 10.3390/brainsci12020160. Brain Sci. 2022. PMID: 35203924 Free PMC article.
References
-
- Bastin C., Salmon E. (2014). Early neuropsychological detection of Alzheimer's disease. Eur. J. Clin. Nutr. 68 1192–1199. - PubMed
-
- Benjamini Y., Hochberg Y. (1995). Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B 57 289–300. 10.1111/j.2517-6161.1995.tb02031.x - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources
